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ABSTRACT
VapD-like virulence-associated proteins have been
found in many organisms, but little is known about
this protein family including the 3D structure of
these proteins. Recently, a relationship between
the Cas2 family of ribonucleases associated with
the CRISPR system of microbial immunity and
VapD was suggested. Here, we show for the first
time the structure of a member of the VapD family
and present a relationship of VapD with Cas2 family
and toxin–antitoxin (TA) systems. The crystal struc-
ture of HP0315 from Helicobacter pylori was solved
at a resolution of 2.8A ˚ . The structure of HP0315,
which has a modified ferredoxin-like fold, is very
similar to that of the Cas2 family. Like Cas2
proteins, HP0315 shows endoribonuclease activity.
HP0315-cleaved mRNA, mainly before A and G nu-
cleotides preferentially, which means that HP0315
has purine-specific endoribonuclease activity.
Mutagenesis studies of HP0315 revealed that D7,
L13, S43 and D76 residues are important for RNase
activity, in contrast, to the Cas2 family. HP0315 is
arranged as an operon with HP0316, which was
found to be an antitoxin-related protein. However,
HP0315 is not a component of the TA system.
Thus, HP0315 may be an evolutionary intermediate
which does not belong to either the Cas2 family or
TA system.
INTRODUCTION
According to the deﬁnition of virulence, virulence
genes can be divided into true virulence genes,
virulence-associated genes and virulence life-style genes
(1). Virulence-associated protein, a product of the vap
gene in various organisms, may be insufﬁcient but requis-
ite for virulence. Generally, vap genes are known as factors
or enzyme-producing factors that regulate the expression
of true virulence genes or activate virulence factors by
translational modiﬁcation, processing of secretion or
that are required for the activity of true virulence
factors. Several vap genes (vapA, B, C, D, H and I) are
known to exist in various organisms (2–8) but how the
products of vap genes are related to virulence remains
unclear. Furthermore, the precise origin of vap sequence
is not clear. Previous studies suggested that the vap regions
may originate from phages via integration events (9).
However, the vap regions also carry genes similar to
plasmid-encoded sequences from other species (5, 9, 10).
VapD, a virulence-associated protein, was identiﬁed in
Dichelobacter nodosus by Katz et al. (5). The exact bio-
logical role of the VapD protein has not yet been estab-
lished, but several suggestions have been made. For
example, VapD in Haemophilus inﬂuenzae is known as a
toxin (11). In Rhodococcus equi, VapA and VapD are
reported to be related to acid tolerance (12). In
Actinobacillus actinomycetemcomitans, the product of
the orf2 gene is known to have high sequence similar-
ity (78.9% amino acid identity) with the vapD of
D. nodosus. That protein is related to plasmid maintenance
and incompatibility (13). vapD has sequence similarity
with the vapBC region and functionally has some connec-
tion with the vapBC operon (6). The vapBC operon
encodes a variant of the bacterial Toxin–antitoxin (TA).
VapBC members are found from Gram-negative,
Gram-positive bacteria and Archaea, while the target of
VapC as a toxin remains unknown. It has been shown that
a toxin of the TA system regulates replication through
DNA gyrase (14,15) or translation through mRNA
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debated, but it is considered as an excellent control mech-
anism of gene expression able to withstand nutritional
stress (19).
Helicobacter pylori is an important pathogen that
infects up to 50% of the human population. It plays an
important role in the pathogenesis of peptic ulcer disease,
distal gastric lymphoma and even adenocarcinoma
(20–22). VapD is present in about 60% of H. pylori strains
(23). Helicobacter pylori strain 26695 has only one type of
virulence-associated protein, VapD. Two genes in this
strain (hp0315 and hp0967) belong to VapD (24). In
many prokaryote genomes, there are sequence homologs
with the VapD family. According to the Pfam database
and BLAST, HP0315 has sequence similarity with the clus-
tered regularly interspaced short palindromic repeats
(CRISPR)-associated protein, Cas2. The products of cas
genes possess functional domains that are typically found
in nuclease, helicases, polymerase and polynucleotide-
binding proteins (25). Recently, Cas2 proteins were found
to be a novel family of endoribonucleases (26).
In this study, we obtained the soluble HP0315 protein
through fusion with the immunoglobulin-binding domain
of streptococcalproteinG (GB1) and solved its crystal
structure. Here, we present the ﬁrst structure of a VapD
family and its possible function. With this ﬁrst VapD
structure, we can gain a foothold in biological and bio-
chemical investigations of VapD proteins.
EXPERIMENTAL PROCEDURES
Cloning of the HP0315 gene
The hp0315 gene was PCR ampliﬁed from H. pylori 26695
genomic DNA using DNA polymerase. The following
primer pair was used: hp0315Fwd (50-CGCGGATCCAT
GTATGCTTTAGCGTTTGATTTAAAG), hp0315Rev
(50-CCGCTCGAGGGATTTCACAATCTCAGTAAAA
TCG). The PCR product was puriﬁed using the
AccuPrepPlasmid Mini Extraction Kit (Bioneer). The
puriﬁed gene was inserted into the modiﬁed pET30a
fused with GB1. The recombinant plasmid was trans-
formed into the Escherichia coli strain BL21(DE3), and
this plasmid was puriﬁed and sequenced to conﬁrm the
exact gene cloning of HP0315 (Bioneer, Daejeon, Korea).
This construct contains N-terminal GB1, which improves
the protein stability dramatically. It also contains
C-terminal eight nonnative residues (LEHHHHHH) to fa-
cilitate protein puriﬁcation.
Protein expression, puriﬁcation and site-directed
mutagenesis
The cells were grown to an OD600 of 0.5 in LB including
100mg/ml kanamycin after which the protein was
overexpressed using 1mM isopropyl-1-thio-b-D-
galactopyranoside (IPTG) for 4h at 37 C. The cells were
harvested by centrifugation at  12000g for 15min
and suspended in 100ml of lysis buffer consisting of
50mM Tris–Cl (pH 8.0), 5% (v/v) glycerol, 1mM
b-mercaptoethanol (bME) and 0.1mM EDTA. Cell lysis
was performed by sonication (duration time 1min, duty
time: 40% with 2min cooling) with a Branson soniﬁer cell
disruptor (Hielscher) in ice. The disrupted cells were
then centrifuged at  16000g for 1h. After centrifugation,
the supernatant was loaded into a His-tag column
equilibrated with the 50mM Tris–Cl (pH 8.0) buffer sup-
plemented with 500mM NaCl, 1mM bME and 0.1mM
EDTA (Buffer A). The pure protein was eluted with an
imidazole gradient from 100 to 300mM imidazole using
FPLC (GE Healthcare), and was subsequently bound to a
second His-tag column. The pooled protein was dialyzed
with Buffer A and concentrated. Finally, the protein was
applied to SuperdexTM 75 gel column (GE Healthcare) in
150mM NaCl, 50mM Tris (pH 7.0), 0.1mM EDTA and
1mM DTT and the pooled protein was concentrated.
To prepare the derivative of GB1_HP0315 substituted
by selenomethionine (SeMet), E. coli BL21(DE3) cells
were grown in 5ml of M9 medium containing 150mg/ml
kanamycin for 12h, spun down, resuspended in 50ml of
M9 medium and then grown at 37 C overnight. This
culture ﬂuid was inoculated into 2 l of M9 medium.
Cells were grown at 37 C, and at an OD600 of 0.5,
50mg/l of selenomethionine, 100mg/l each of Phe, Thr
and Lys and 50mg/l each of Leu, Ile, Val and Pro were
added to block the methionine biosynthesis and to allow
selenomethionine substitution (27). IPTG was added
20min later and the culture was harvested after 4h.
Expression and puriﬁcation of SeMet-substituted protein
were conducted by the same method as described above
for the native protein.
Site-directed mutagenesis of GB1_HP0315 was carried
out using the QuikChange site-directed mutagenesis kit
(Stratagene).
Gel ﬁltration experiment
A gel ﬁltration experiment was conducted to determine
the size of the GB1_HP0315. To standardize the column
with known molecular weights, the LMW Gel Filtration
Calibration Kit (Amersham Pharmacia Biotech) was used.
The kit includes ribonuclease A (13.7kDa), chymotryp-
sinogen A (25kDa), ovalbumin (43kDa), bovine serum
albumin (67kDa) and blue dextran 2000. GB1_HP0315
and molecular weight standards were applied on a
BioSep-SEC-S 3000 (Phenomenex) gel ﬁltration column.
The molecular weight was calculated as follows:
Kav=(Ve–Vo)/(Vt–Vo). The total volume of the resin
(Vt) was measured with tyrosine, the void volume (Vo)
with blue dextran and Ve with the standards and
GB1_HP0315. The standard curve was generated by
plotting Kav against the logarithm of the molecular
weight of the standard proteins. By applying the Kav
value of GB1_HP0315 to the standard curve, its molecular
weight was roughly estimated.
Crystallization and data collection
The SeMet-substituted protein was crystallized by
hanging-drop vapor diffusion method at 293K against a
reservoir solution containing 0.2M (NH4)2SO4, 9% (w/v)
PEG3350, 5–8% (v/v) glycerol, 100mM2-(N-morpholino)
ethanesulfonic acid [MES (pH 6.0)]. Typical crystals were
obtained within 3 days. The crystals grew up to
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For cryo protection, crystals were transferred to a
cryoprotecting solution containing 0.25M (NH4)2SO4,
10% (w/v) PEG3350, 20% (v/v) glycerol and 100mM
MES (pH 6.0) for <2min in several steps and ﬂash-cooled
in a stream of nitrogen gas at 100K. A set of Se Single
Anomalous Scattering (SAS) data was collected at
0.97951A ˚ using an Area Detector System Corporation
Quantum 210 charge-coupled device detector at the
beam line 4A of Pohang Light Source (PLS), Korea.
The crystal was rotated through a total of 180  with a
1.0  oscillation range per frame. The data were processed
and scaled using the program suit HKL2000 (28). The
SeMet-substituted crystal belongs to the space group
P3121 with unit cell parameters of a=77.81A ˚ ,
b=77.81A ˚ and c=106.31A ˚ . The data collection and
processing statistics are summarized in Table 1.
Structure determination and reﬁnements
The asymmetric unit of GB1_HP0315 crystal contains two
molecules. Therefore, the crystal of Se-GB1_HP0315
contains four Se sites (ﬁrst methionine residue from each
GB1 monomer and methionine residue from each HP0315
monomer) in the asymmetric unit. Two selenium sites (of
the Se–Met from HP0315) were located with the program
SnB (29) using single anomalous scattering (Se peak) data.
Two Se–Met sites were used to generate initial phases and
initial partial model was built using the program
RESOLVE (30). About 50% of the model could be con-
structed and a more complete model was built with Coot
(31). One GB1 part of the two monomers could not be
traced. Rigid body reﬁnement followed by torsional
simulated annealing and group B factor reﬁnement
reduced the R-factors to Rwork=0.283, Rfree=0.357.
The initial model was subjected to iterative cycles of
manual model building with COOT, and crystallographic
reﬁnement by CNS (32,33). Solvent molecules became
apparent in the later stages of reﬁnement and were
added into the model. Further reﬁnement was pursued
until no further decrease of the Rfree was observed
(Rwork=0.250, Rfree=0.284). The values of Rwork and
Rfree are a little high because we could not trace one
GB1 part of the two monomers. The ﬁnal model exhibited
good stereochemical geometry (Table 1). All stereochem-
ical parameters are within the expected margins and the
Ramachandran plot shows 85.9% of residues in the most
favored and 14.1% in the additional allowed region, with
none in the generously allowed or disallowed region as
deﬁned in PROCHECK (34). Reﬁnement statistics are
summarized in Table 1. Coordinates and experimental
structure factors of the GB1_HP0315 structure have
been deposited in the Protein Data Bank with accession
code ID 3UI3.
Generation of RNA substrates
HP0315 mRNA substrate was synthesized using the
Ambion T7 RNA polymerase MEGAscript high yield
transcription kit (Ambion). The long mRNA (308nt) sub-
strate of hp0315 was synthesized using in vitro transcrip-
tion reaction. DNA template with a T7 promoter site was
prepared by PCR and the following pair of primers was
used: Fwd (50-TAATACGACTCACTATAGGGGAATT
GTGAGCGGATAACAATTC), Rev (50- CTCCGTATT
CTTTTTTTAAAATCTC). The short RNA substrates
were synthesized by Integrated DNA Technologies
(IDT, Coralville, IA, USA).
RNase activity assay
Puriﬁed recombinant GB1_HP0315 protein from H. pylori
(10mM) was incubated at 37 C with the nucleic acid sub-
strates (1mg dsDNA (308nt), 2mg ssDNA (42nt) and 1mg
ssRNA (308nt)) in the presence of 200mM Tris (pH 7.0)
for 60min. RNase activity assay was carried out at various
pH levels (pH 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0 and 11.0). In
each reaction, no metal, 2.5mM Mg
2+,M n
2+,C o
2+ or
Ca
2+ was added, respectively. RNase activity was tested
with no monovalent ion, Na
+from 100 to 500mM and K
+
from 100 to 400mM.
A ﬂuorescence experiment proceeded according to the
manual of RNaseAlert (IDT). RNaseAlert is a sensitive
assay designed for the detection of RNase activity.
Basically, a ﬂuorescent-labeled RNase substrate that
contains a quencher on one end and a ﬂuorescent molecule
on the other emits green ﬂuorescence if it is cleaved by
RNase. The ﬂuorescence emitted from cleavage of the
Table 1. Crystallographic data collection and reﬁnement statistics
Data collection
Beam line BL-4 A (PLS)
Wavelength (A ˚ ) 0.97951
Resolution range (A ˚ ) 30.0–2.80 (2.90–2.80)
a
Space group P3121
Unit cell parameters (A ˚ ) a=77.81 b=77.81 c=106.31
Observations (total/unique) 103334/9568
Completeness (%) 99.8 (100.0)
Redundancy 10.8 (11.0)
Rsym
b 8.3 (53.0)
I/  57.4 (5.1)
Phasing
Phasing power 0.84
Figure of merit 0.44
Reﬁnement
Rwork
c (%) 25.0
Rfree
c (%) 28.4
Protein atoms 2044
Water molecules 6
Average B value (A ˚ 2) 54.1
r.m.s.d. from ideal geometry
Bond length (A ˚ ) 0.007
Angles ( ) 1.210
Ramachandran analysis (%)
Most favored region 85.9
Additional allowed region 14.1
Generously allowed region 0.0
Disallowed region 0.0
aNumbers in parentheses indicate the statistics for the last resolution
shell.
bRsym=
P
jIhkl–<Ihkl>j/
P
<Ihkl>, where Ihkl=single value of
measured intensity of hkl reﬂection, and <Ihkl>=mean of all
measured value intensity of hkl reﬂection.
cRwork=
P
jFobs–Fcalcj/
P
Fobs, where Fobs=observed structure factor
amplitude, and Fcalc=structure factor calculated from model. Rfree is
computed in the same manner as Rwork, but from a test set containing
10% of data excluded from the reﬁnement calculation.
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490nm. GB1_HP0315 (10mM) was incubated at 37 C
with a ﬂuorescence substrate (50pmol) in the presence of
20mM Tris (pH 7.0) and 10  RNaseAlertTM buffer for
180min.
Primer extension inhibition assay
The HP0315 mRNA was used as a template. Each speciﬁc
DNA primer was synthesized and 50 labeled with
[g-
32P]ATP using T4 polynucleotide kinase. Primer
(0.8pmol) was mixed with each template (1pmol) in a
reaction buffer to a total volume of 20ml. The mixture
was heated to 90 C for 5min and then slowly cooled to
room temperature. The reaction mixture was digested by
adding various amounts of GB1_HP0315 protein at 37 C
for 30min. A subsequent primer extension reaction was
performed by adding 8mlo f5   buffer [250 mM Tris–HCl
(pH 8.3), 375mM KCl and 15mM MgCl2], 5mM DTT,
0.5mM dNTP and 40 U of Superscript III reverse tran-
scriptase (Invitrogen) for a ﬁnal reaction volume of 40ml.
cDNA was synthesized at 55 C for 30min after which the
products were subjected to 10% (w/v) denaturing PAGE
and analyzed by autoradiography.
Enzymatic assay against short RNAs
Based on the primer extension products of the
pre-digested RNA, the region around the most frequently
cleaved site was selected for the short RNA cleavage
assay. The short RNA substrates were purchased from
IDT and 50 labeled with [g-
32P]ATP using T4 polynucleo-
tide kinase. The labeled RNA substrates (1pmol) were
mixed with 10mg (0.56pmol) of GB1_HP0315 protein in
a reaction buffer in a total volume of 20ml. The mixtures
were incubated at 37 C for 30min. The reaction was
quenched by the addition of an equal volume of
formamide loading buffer [80% (v/v) formamide,
0.025% (v/v) bromophenol blue, 0.025% (v/v) xylene
cyanol and 10mM EDTA (pH 8.0)]. The reaction
products were resolved by electrophoresis in 15% (w/v)
polyacrylamide and 8M urea gels using TBE buffer. As
nucleotide size markers, an imidazole ladder was prepared
by partial RNA cleavage by imidazole. The labeled RNA
substrates (1pmol) were incubated in 2M imidazole and
0.5mM EDTA (pH7.0) in a total volume of 20mla t9 0  C
for 10min. An equal volume of formamide loading buffer
was then added.
RESULTS
Stability improvement of HP0315
The hp0315 gene was initially cloned into the pET-21a(+)
vector to produce the C-terminally His-tag fused protein
product. This native protein was unstable at a protein
concentration that exceeded 20mM and precipitated
easily. GB1 is a relatively small fusion protein among
fusion proteins such as glutathione S-transferase (GST)
and maltose-binding protein. For this reason, GB1 is
quite advantageous when used in structural studies using
NMR or crystallography, which means that structural
studies of protein fused with GB1 can be done even
without the cleavage of the fusion tag (35). In our study,
solubility of HP0315 was greatly improved by N-terminal
GB1 tagging. GB1_HP0315 could be concentrated
without any precipitation. To evaluate whether the
native structure of GB1_HP0315 was well maintained,
the secondary structure of the fusion protein was
analyzed. As GB1 is a small protein made up of 23%
helical and 39% b sheet secondary structures (PDB ID:
2GB1), it is predicted that GB1 does not have much of an
effect on the CD spectra of GB1_HP0315. The prediction
was in good agreement with the results of the CD spectra.
Two CD spectra (with and without GB1) were similar to
each other, indicating that at least the secondary structure
of HP0315 was not changed by the fusion protein, GB1
(Supplementary Figure S1).
Dimeric state of HP0315
The molecular weight of GB1_HP0315 was estimated to
be 17.4kDa from the protein sequence. As shown in
Supplementary Figure S2, the apparent molecular weight
of GB1_HP0315 was determined to be  41kDa, which
indicated that GB1_HP0315 could be a dimeric protein
with a molecular weight of 34.8kDa. This result means
that HP0315 has a dimeric structure, as GB1 itself is a
monomeric protein.
Overall structure of HP0315
The dimeric structure of HP0315 fused with a GB1 protein
at each N-terminus was determined at a resolution of
2.8A ˚ . The structure of HP0315 from H. pylori consists
of 10 secondary structure elements: b1 (residues 1–8), a1
(residues 10–17), a10 (residues 21–35), b2 (residues 38–41),
b3 (residues 44–47), a2 (residues 53–66), a20 (residues
68–73), b4 (residues 75–87) and a3 (residues 88–93). The
monomer has a ferredoxin-like fold. It has the b1-(a1-a10)-
b2-b3-(a2-a20)-b4-a3 instead of the b-a-b-b-a-b structure
of the ferredoxin fold. In the ﬁrst half of the monomer, a1
is shorter than a10 and, in the last half of the monomer, a2
is longer than a20. The a10 and a2 helices have amphipath-
ic property, and the hydrophobic side of these amphipath-
ic helices faces the inner space. Many hydrophobic
residues facing the protein interior form a hydrophobic
core for structural stability, which give the structure com-
ponents stability (Figure 1D and E). In addition, the b
strands are stabilized by direct hydrogen bonds between
neighboring b-strands.
The dimer of HP0315 is butterﬂy shaped (Figure 1A).
The b4 strand and the a3 helix associate with the adjacent
monomer, forming a dimerization interface. Direct
hydrogen bonds between b4 from one monomer and b4
from the other monomer contribute to dimerization. The
area of the calculated dimerization interface is 2900 A ˚ 2.
This area represents 29.3% of the total solvent-accessible
surface area of a dimer. HP0315 forms a dimer with
a root-mean-square difference (r.m.s.d.) of 0.362A ˚
between two monomers (Figure 1B), with small differ-
ences in the loop between b2 and b3 and a C-terminal
region between the monomers.
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structure of HP0315. The solvent-accessible residues on
the inside of the deep channel can be considered as a
putative active site. The two pinnacles surrounding the
channel are positively charged (Figure 1C), indicating
that they may be putative RNA-binding sites. In the
light of these observations, the RNA-binding region and
the putative active site region appear to be slightly
separated from each other.
Figure 2A shows the distribution of the a carbon
B-factor of the A molecule in the HP0315. High
B-factor regions are located on a1 helix, the loop
between b2 and b3 strands, the loop between b3 strand
and a2 helix, and the C terminal tail (Figure 2B).
A
C
DE
B
Figure 1. Structure of HP0315 from H. pylori.( A) Cartoon representation of dimer of HP0315 (a-helices, b-strands and loops are cyan, magenta and
yellow, respectively). Dotted circle represents the putative catalytic region located at deep cavity region. (B) Superposition of molecules A and B from
HP0315 with an average r.m.s.d. of 0.362A ˚ . Two molecules are slightly different from each other in the loop between b2 and b3 and C-terminal
region. (C) Surface representation of HP0315 showing positive electrostatic potential in blue and negative in red. Dotted circle represents the putative
RNA-binding region. This region would be related to initial binding with RNA, and then second catalytic reaction would be happen around deep
cavity region. (D) The image seeing down from top indicates that highly conserved residues (F6, L13, Y25, F37, Y45 and V74) from the result of
structure based sequence alignment are concerned with hydrophobic interaction. Hydrophobic residues are colored in red and hydrophilic residues
are in blue, respectively. (E) This ﬁgure shows that clustered hydrophobic residues into inside form the hydrophobic interaction core. All ﬁgures were
prepared using PyMOL (52).
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The molecular function of VapD is unknown. As a ﬁrst
step toward a functional evaluation, we performed a
sequence-based homology search (Figure 3A). There are
many sequence homologs among the proteins of the VapD
family. In particular, residues in the ﬁrst b-strand (b1), the
loops between b2 and b3, and C-terminal region are highly
conserved (Figure 3A). By considering that the C-terminal
conserved region resulting from sequence alignments is
related to dimerization, it is thought that the other
region may contain active-site residues.
According to the Pfam database, HP0315 is related to
the CRISPR-associated protein Cas2, with an E-value
4.1e-08. In addition, Makarova et al. (6) investigated the
interrelationships between VapD and Cas2 proteins.
According to the aspects of the sequence and/or structure
(see the structural homologs part), VapD was determined
to be a protein that was related to the Cas2 proteins.
However, a CRISPRs sequence composed of 25–50bp,
which is characteristic of Cas2 proteins, was not found
near the hp0315 gene.
The result of the H. pylori genome analysis indicates
that there is another interesting feature. The two genes
hp0315 and hp0316 exist as an operon, which is a func-
tional unit of genomic DNA containing partially
overlapped genes under the control of a single regulatory
signal or promoter (gene coordinates: hp0315 330872–
330588, hp0316 331245–330853) (Supplementary Figure
S3A) (36). HP0316 is an unknown protein and has a
sequence similarity of 88.9% with HP0895 (Supplemen-
tary Figure S3B). Recently, HP0895 provided a clue
about the function of HP0316 (37). hp0895 forms an
operon with hp0894, and this operon was found to be a
TA system. HP0894 is known as a toxin possessing RNase
activity. Based on this similarity, despite the fact that
HP0315 has no sequence and structural homology with
HP0894, we postulated that HP0315 may have the same
role as HP0894. To test whether HP0315 is a toxin or
not, we undertook a HP0315–HP0316 binding assay.
The result of a His-tag pull-down assay indicated that
HP0315 did not bind to HP0316 (Supplementary Figure
S3C). Furthermore, in vivo toxicity experiments revealed
that HP0315 and HP0316 do not form a TA system
(Supplementary Figure S3D). Therefore, the biological
roles of HP0315 and HP0316 should be different from
those of HP0894 and HP0895.
Structural homologs
A DALI search (38) using the dimer structure may supply
a possible function of this molecule. Nine structures were
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Figure 2. Structural analysis according to a carbon B-factor. (A) The distribution of a carbon B-factor of each residues. The regions with high a
carbon B-factor are colored under red. (B) High distribution of a carbon B-factor is represented with red color on the cartoon structure of HP0315.
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EF
Figure 3. Structure-based sequence analysis of HP0315 with other proteins belonging to VapD family and Cas2 proteins. (A) Residues conserved in
all VapD family are colored under dark blue, highly conserved residues under medium blue and somewhat conserved residues under light blue. The
secondary structure elements derived from the structure of HP0315 are displayed above the alignment. Residues marked with arrow were highly
conserved among VapD family and selected as candidates for mutational studies. Residues with red arrow are related to catalytic activity based on
mutational study. The compared proteins are as follows: HP0315 (NCBI accession ID: NP_207113), DNO_0265 (YP_001209119) from D. nodosus,
HIAG_00714 (ZP_05850077) from H. inﬂuenza, NGK_p0009 (YP_002000622) from N. gonorrhoeae, PRU_1589 (YP_003574888) from P. ruminicola,
VEIS_4994 (YP_999698) from V. diseniae, CAG_1570 (YP_379868) from C. chlorochromatii, HSM_1448 (YP_001784768) from H. somnus.
(B) Structure-based sequence analysis of Cas2 proteins. Residues are colored like above sequence alignment. Residues marked with red box of
SSO1404 are important for the catalytic activity of SSO1404 (26). The compared proteins are as follows: SSO1404 from S. solfataricus, SSO8090,
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(continued)identiﬁed with a Z-score between 6.0 and 6.8. All of them
have a ferredoxin-like fold. With only Z-scores that
exceeded 6.4, the DALI program ﬁltered the top three
hypothetical unknown proteins (Supplementary Figure
S4), TT1823 from Thermus thermophilus (Z=6.8, PDB
ID 1zpw r.m.s.d. 2.2A ˚ ), SSO8090 from Sulfolobus
solfataricus (Z=6.8, PDB ID 3exc r.m.s.d. 2.4A ˚ ) and
PF1117 from Pyrococcus furiosus (Z=6.4, PDB ID 2i0x
r.m.s.d. 2.5A ˚ ). The molecules with the next highest
Z-scores with known functions were the adenylyl cyclase
fragment (Z=5.9, PDB ID 1y11) and various ribosomal
proteins.
According to the Pfam database, the top three proteins
above belong to Cas2 family. A function was reported on
one of the Cas2 proteins (Z=6.0 PDB ID 2ivy) (26),
although it did not belong to top three proteins in our
DALI search. The reported structure of SSO1404 (PDB
ID 2ivy r.m.s.d 3.1A ˚ ) from S. solfataricus can be a repre-
sentative structure of the proteins associated with the
CRISPRs (6). Cas2 proteins are a product of the cas2
gene, one of the two cas (CRISPR-associated) genes,
cas1 and cas2, belonging to the COG1343 and
COG3512 groups of the clusters of orthologous groups
(COG) classiﬁcation system (6, 39). The overall structures
of VapD and SSO1404 (26) are very similar to each other,
although there are some differences in the distribution of
the secondary structure elements. The major difference is
in the b4 strand region of VapD, which was replaced by a
helix in SSO1404. Another difference lies at the a1 region
of VapD which was replaced by a loop in SSO1404. The
homodimer interface part for both proteins shows a high
level of structural similarity. This interface part corres-
ponds to the N-terminal region of VapD. Those residues
that are highly conserved in VapD shown as by the
Consurf program (40–42) appear to correspond well to
the active site region of SSO1404 and appear to be
mainly distributed on the interface region of the dimer
structure (Figure 3C, D and Supplementary Figure S5).
A comparison of the key residues of SSO1404 with the
corresponding residues of HP0315 shows that Y9, D10
and F37 of SSO1404 are remarkably conserved as F6,
D7 and Y45 of HP0315, respectively (Figure 3B, E and
F). From the structure and structure-based alignment of
key residues, we speculate that HP0315 may show ribo-
nuclease activity.
Enzymatic activity of HP0315
The results presented in the previous section showed that
HP0315 may display ribonuclease activity, similar to Cas2
proteins. To identify the biochemical activity of HP0315,
we performed a primer extension experiment as well as
agarose-based nuclease experiments. The puriﬁed protein
and various nucleotide substrates including linear double-
stranded DNA (dsDNA: PCR ampliﬁed of hp0315 gene,
308nt), linear single-stranded DNA (ssDNA: C-terminal
oligonucleotide of hp0315 gene, 42nt) and single-stranded
RNA (ssRNA: in vitro transcript of hp0315 gene, 308nt)
were used to test for nuclease activity (Figure 4A).
Interestingly, GB1_HP0315 cleaved only ssRNA among
them. In addition, GB1_HP0315 showed RNase activity
over a broad range of pH with the maximum activity
at pH 7.0–7.5 (Figure 4B). Although some nucleases,
including Cas2 proteins, show the highest level of
activity in the presence of divalent cations, e.g. Mg
2+
and Mn
2+ (26,43,44), the ribonuclease activity of
GB1_HP0315 was not dependent on metal ions with
ranges of Mg
2+ and Mn
2+ concentrations of 1, 10,
50, 100mM, 1 and 2.5mM (Figure 4C) (data are not
shown). In addition to divalent ions, the RNase activity
of GB1_HP0315 was not inﬂuenced by monovalent ions.
We performed agarose-based electrophoretic mobility
shift assays according to the concentration of the mono-
valent ions of Na
+ or K
+ ions from 0 to 400mM.
However, in the case of GB1_HP0315, the RNase
activity was not signiﬁcantly inﬂuenced by the Na
+ or
the K
+ ions (Figure 4D).
Cleavage of the long mRNA
To conﬁrm the RNase activity of HP0315 and to identify
the cleavage site of the mRNAs of HP0315, primer
extension inhibition experiments were performed. As
a result, GB1_HP0315 predominantly cleaved mRNAs
before adenine (A) and guanine (G) (Figure 5).
Therefore, HP0315 is expected to be a purine-speciﬁc
endoribonuclease.
Cleavage of short RNAs
To identify the limitation of the mRNA length which can
be cleaved by GB1_HP0315, various short-length RNA
templates (from 14 to 6nt) were used for an RNase
activity test (Figure 6). Initially, we tested the sequence
(50-GACUUUAGCGAUUU-30: 14nt) including a cleav-
able site, based on the primer extension results. Other
small RNA templates were prepared by cutting 2nt (1nt
at each terminal site). As shown in Figure 6, GB1_HP0315
could cleave at least 6nt RNA. RNAs shorter than 6nt
were not tested due to the technical difﬁculty associated
with this type of synthesis.
Putative active site and mutational study of HP0315
It is expected that the residues which are important for
RNase activity meet the following conditions: (i) residues
Figure 3. Continued
TT1823 from T. thermophilus and PF1117 from P. furiosus.( C) Important residues for its activity of HP0315. According to mutational study,
D7, L13, S43 and D76 are important residues for its activity. D7 and D76 are supposed to be a nucleophile which can attack and cleave
phosphodiester bond of ssRNAs. L13 located on the a1 helix region can affect the local environment of a1 helix which is a candidate for ﬁrst
RNA-binding region using positive residues. S43 located between b2 and b3 might bind with uracil base, which might help the speciﬁc cleavage of
RNA. (D) Important residues for its activity of SSO1404. D10 is known as a catalytic active site (26). (E) Superposition of HP0315 and SSO1404.
HP0315 is colored by cyan and SSO1404 is colored by magenta. (F) Superposition of key residues of SSO1404 with the corresponding residues of
HP0315. The sequences were aligned by CLUSTALW2 (53), and the ﬁgure was generated using Jalview (54).
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VapD proteins and (ii) residues that are conserved by the
structure-based sequence alignment of HP0315 and
selected Cas2 proteins.
Referring to the two criteria, several residues were
selected: Phe-6, Asp-7, Leu-13, Tyr-25, Phe-37, Trp-39,
Gln-41, Ser-43, Tyr-45, Val-74 and Asp76. To identify
the residues required for its activity, we performed
alanine mutagenesis screening of the above residues. All
of the selected residues did not have direct relevance to the
catalytic active site. Among the selected residues, some
residues appear to be connected to the folding and/or sta-
bility of the structure, as F37A and V74A seriously
reduced the stability of HP0315 and thus could not be
puriﬁed. D7A, L13A, S43A and D76A signiﬁcantly
reduced the ribonuclease activity of GB1_HP0315
(Figure 4E).
The F6, L13, Y25, F37, Y45 and V74 residues appeared
to be more involved with maintaining the structure of the
key catalytic region than with the catalytic activity itself.
As stated earlier, the above residues face into the inside of
the structure, forming a hydrophobic core (Figure 1D).
Especially, L13 contributes to the stability of a1 helix.
As the a1 helix is located at the top of the dimer structure
(Figure 1D), it may be a candidate for the initial RNA
binding.
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Figure 4. Enzymatic activity experiments. (A) Lane 1 is ssRNA alone. Lane 2 is ssRNA with GB1_HP0315. Lane 3 is dsDNA with GB1_HP0315.
Lane 4 is ssDNA with GB1_HP0315. (B) Lane C is RNA alone, lane 1 is at pH 7.0, lane 2 at pH 7.5, lane 3 at pH 8.0, lane 4 at pH 8.5, lane 5 at pH
9.0, lane 6 at pH 9.5, lane 7 at pH 10.0 and lane 8 at pH 11.0. Some precipitations are occurred at and below pH 6.0. (C) Lane C is RNA alone and
lane 1 is RNA and GB1_HP0315 without divalent cation. Lane 2 is RNA and GB1_HP0315 with 2.5mM Mg
2+ ion, lane 3 with 2.5mM Mn
2+, lane
4 with 2.5mM Co
2+ and lane 5 with 2.5mM Ca
2+ (D) Lane C is RNA alone. Lane 1 is RNA and GB1_HP0315 with no monovalent ion. Lane 2 is
RNA and HP0315 with 100mM NaCl, lane 3 is with 200mM NaCl, lane 4 is with 300mM NaCl, lane 5 is with 400mM NaCl and lane 6 is with
500mM NaCl. Lane 7 is RNA and HP0315 with 100mM KCl, lane 8 is with 200mM KCl, lane 9 is 300mM KCl and lane 10 is with 400mM KCl.
(E) Ribonuclease activity of mutated GB1_HP0315 using ﬂuorescence. A ﬂuorescent substrate is incubated with various mutated GB1_HP0315 in
same condition. When ﬂuorescence-quenched oligonucleotide probes are cleaved, ﬂuorescence can be appeared in the process of time. Wild-type
protein of HP0315 cleaved the substrate most quickly. F6A, Y25A, Q41A, Y45A, W39A, D76A, D7A, S43A and L13A showed highest RNase
activity in order. This result clearly indicates that D7, L13, S43 and D76 are most important residues for ribonuclease activity.
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VapD, the product of a virulence-associated gene with
about 90 amino residues, is present in most bacterial
species. Thus far, little information on VapD has been
available but, in this article, we describe the ﬁrst structural
and biochemical characterization of VapD.
Comparisons of the structure of HP0315 with those of
other homologs belonging to the Cas2 family as well as the
result of a sequence blast strengthened the functional re-
lationship between HP0315 and Cas2 proteins. For this
reason, HP0315 was assumed to display ribonuclease
activity, similar to Cas2 proteins. As expected, our study
shows that HP0315 displays ribonuclease activity speciﬁc
to ssRNA substrates. For an accurate assessment of the
ribonuclease activity, in our experiments, we excluded the
presence of any trace of imidazole and guanidinium de-
rivatives, which also have weak ribonuclease activity (45).
The appearance of the overall monomeric structure of
HP0315 is similar to those of the Cas2 proteins, particu-
larly the b-strands (Figure 3E). Furthermore, the key
residues on the b strands, Y9, D10 and F37, from
SSO1404, a recently reported Cas2 protein, correspond
very well to F6, D7 and Y45, respectively, of HP0315
(Figure 3F). However, the mechanism of SSO1404
activity is somewhat different from that of HP0315. The
basic principle of the mechanism suggested for the activity
of SSO1404 begins with coordination between Mg
2+ and
two D10 residues from dimer molecules. These two Asp
residues from SSO1404 dimer molecules can create coord-
ination with a Mg
2+ ion, as the distance between the
side chains from the two Asp residues is only 6.5A ˚
(Figure 3D). However, in the case of HP0315, the
distance between the side chains of two instances of D7,
which is the corresponding residue of D10 of SSO1404, is
around 12.5A ˚ (Figure 3C), which complicates the coord-
ination between Mg
2+ (or any other metal ion) and the
two Asp side chains. In fact, HP0315 showed ribonuclease
activity without the addition of metal ions. In our muta-
tional studies, D7 of HP0315 was also found to be an
important residue for its ribonuclease activity, like the
corresponding residue D10 of SSO1404. However, it
may have a different role from the previously mentioned
mechanism of SSO1404. Besides D7, our mutational
screen results indicated that L13, S43 and D76 could
also be considered as important residues for ribonuclease
activity. The D7, L13 and D76 residues are located in b1,
a1 and b4, respectively, and the S43 residue is located on
the short-turn region between b2 and b3 (Figure 3C).
It was expected that D7 and D76 were catalytic residues
for ribonuclease activity because these are most highly
conserved from the sequence blast as well as acidic
amino acid, which must be a catalytic nucleophile for
RNA cleavage. We do not know the exact mechanism of
these two aspartic residues as a nucleophile due to the
deﬁciency of complex structure. However, considering
the results of mutational studies and the comparison
with Cas2, two aspartic residues are strong candidates as
a catalytic site.
As mentioned previously, it has been predicted that a1
is an important region for RNA binding, considering the
distribution of positive charges on the electropotential
map. Interestingly, an analysis of the B factor indicates
that the a1 helix has relatively high a carbon B-factor
values (Figure 2). That is, some residues on these
regions have atomic movements containing residue ﬂexi-
bility and/or conformational changes (46). These high
B-factor values and the location of the top position
strongly suggest that the residues on the a1 helix can be
candidates for interacting with RNA. In a protein–protein
or protein–nucleic acid interaction system, protein ﬂexibil-
ity and/or intrinsic disorder can be an important charac-
teristic for interacting (47). The a1 helix is stabilized by the
hydrophobic interaction between the hydrophobic core
and L13. Consequentially, L13A could give rise to
serious changes in the environment around the a1 helix,
Figure 5. Primer extension inhibition analyses of mRNA cleavage by
GB1_HP0315. Lanes 1–4 are DNA sequence ladders. Lane 5–9 is
primer extension products of mRNA of HP0315 after digestion with
various amounts of GB1_HP0315. Cleavage sites are indicated by se-
quential numbers on right side of the images. The RNA recognition
sequences analyzed by the DNA sequencing ladder are on bottom side
of the images. Preferential cleavage sites are mainly before the bases
A and G.
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between the protein and the RNA.
Our result revealed that RNA cleavage occurs before
the purine residues, which implies the X:Ao rX :G sites
(X: any nucleotide), but the preferential site cleaved most
efﬁciently is U:A (Figure 5 and Supplementary Figure S6).
In the case of ribonuclease A (48), a side chain of serine in
the catalytic region is known to form a hydrogen bond
with uracil. Thus it is associated with the speciﬁcity of
ribonuclease. HP0315 mostly cleaved just before the
purine residues, but it frequently cleaved between U and
A, which may be mediated by S43 in a similar way.
Moreover, the loop region containing S43, between the
b2- and b3-strands, also shows a high B-factor value,
which can be evidence of interaction between the S43
residue and uracil.
Therefore, we speculate that D7 and D76 are related to
the catalytic activity, while L13 and S43 seem to be
associated with the related speciﬁcity. This indicates that
HP0315 has a similar structure but not an identical
mechanism to cleave ssRNAs compared to SSO1404.
Therefore, the present results strongly suggest that
HP0315 is a member of a novel ribonuclease family
other than the Cas2 family.
It was previously reported that VapD is functionally
linked to the VapBC TA system (6). The genes of hp0315
and hp0316 are arranged as an operon. Interestingly,
HP0316 has a high sequence homology with HP0895, anti-
toxin from H. pylori, which was reported recently by our
group (37). This type of gene arrangement of hp0315 raises
the possibility that HP0315 belongs to the TA system as a
toxin. However, HP0315 did not bind to HP0316 based on
the results of a His-tag pull-down assay. HP0315 and
HP0316 did not show TA activity in an E. coli viability
test, either. This suggests that HP0315 and HP0316 do
not belong to a TA system. Moreover, not only HP0967,
another VapD protein from H. pylori, but also most VapD
proteins from various organisms do not exist as an operon.
This gene arrangement of HP0315 is very unique in this
respect among the VapD family.
It was also reported that VapD is distantly related to
Cas2 proteins and linked to the TA system (49). However,
little evidence of this has been published. In this work,
we revealed that HP0315, a member of the VapD
family, has structural similarity with the Cas2 family
and has gene arrangement similarity to the TA system,
whereas it does not belong to any of them, like an evolu-
tionary intermediate. Our result can serve as direct
evidence that proves the previously reported suggestions
(49). The facts that HP0315 is related to Cas2 proteins and
TA system and has ribonuclease activity provide some
information about the function of HP0315. The global
inhibition of translation by mRNA cleavage would be a
basic principle pertaining to the biological role of both
Cas2 proteins and TA systems, including RelBE,
MazEF, PemIK and ChpBIK (19,26,50,51). The exact
function of HP0315 has not been determined. However,
considering its relationship with Cas2 and the TA system,
the role of HP0315 based on endoribonuclease activity
may be related to either cell maintenance or a defense
mechanism against invasion or possibly both like Cas2
and/or the TA system.
This structural study is the ﬁrst step toward the under-
standing of the biological meaning of this protein and
related predictions involving it in H. pylori virulence.
ACCESSION NUMBER
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Figure 6. Cleavage experiments of small RNAs. Lanes M are imidazole ladder marker, which was prepared by partial RNA cleavage by imidazole.
Lane 1 is 14nt ssRNA without GB1_HP0315, and Lane 2 is 14nt ssRNA with GB1_HP0315. Lane 3 is 12nt ssRNA alone and Lane 4 is 12nt
ssRNA with GB1_HP0315. Lane 5 is 10nt ssRNA alone and Lane 6 is 10nt ssRNA with GB1_HP0315. Lane 7 is 8nt ssRNA alone and Lane 8 is
8nt ssRNA with GB1_HP0315. Lane 9 is 6nt ssRNA alone and Lane 10 is 6nt ssRNA with GB1_HP0315. Cleavage sites are indicated by closed
triangles.
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